Startups
Intrance Medical
Edit

Intrance Medical

https://www.intrancemedical.com/
Last activity: 13.03.2025
Active
Categories: DevelopmentMedTechProduct
Intrance Medical Systems is focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson's disease in the U.S., Canada, Mexico, South America, Japan and Taiwan.
Mentions
8

Overview

Total raised
$25M

Investors 1

DateNameWebsite
Sign up to seeSign up to seeSign up to see

Funding Rounds 2

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see
Sep 20, 2021Series A round$8M

Mentions in press and media 8

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Apr 27, 2023Tridentify AB signs Letter of Intent with Intrance Medical Systems Inc regarding purchase and delivery of its SaaS based cold chain safeguarding serviceTridentify AB signs Letter of Intent with Intrance Medical Systems Inc regarding purchase and delivery of its SaaS based cold chain safeguarding service Thu, Apr 27, 2023 14:00 CET Report this content Tridentify AB has today signed a Letter...
Jan 4, 2022Intrance Medical Systems Raises $17M in Series A FundingIntrance Medical Systems, Inc., a New York-based biopharmaceutical company and a subsidiary of Sweden-based Intrance Holdings AB, raised $17M in Series A funding. The round was led by Erik Selin and Rutger Arnhult. The company intends to us...
Jan 4, 2022Intrance Medical Systems Completes $17 Million Series A Financing and Appoints Ed Schutter to Board of DirectorsIntrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced that it has completed the final round of a Series A financing, totaling USD $17 million. Internationally well renowned Scandinavian investors,...
Nov 2, 2021Leading US-Swedish entrepreneur Rutger Arnhult invests in Intrance Medical Inc’s advanced stage Parkinson’s disease treatment systemLeading US-Swedish entrepreneur Rutger Arnhult invests in Intrance Medical Inc’s advanced stage Parkinson’s disease treatment system Tue, Nov 02, 2021 08:00 CET Stockholm, Sweden, November 2, 2021: Leading US-Scandinavian real estate entrep...
Sep 20, 2021Intrance Medical Systems Raises $8M in Series A FundingIntrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, secured USD $8m in funding. Swedish real estate investor Erik Selin made the investement through his private company, Erik Selin Fastigheter AB. Mr. Selin has...
Sep 20, 2021Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson's DiseaseIntrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced the company has secured USD $8 million from prominent Swedish real estate investor Erik Selin through his private company, Erik Selin Fastighe...
Sep 20, 2021Intrance Medical Systems Raises $8 Million to Support Development of its Innovative Therapy for Advanced Parkinson’s DiseaseIntrance Medical Systems Raises $8 Million to Support Development of its Innovative Therapy for Advanced Parkinson’s Disease Mon, Sep 20, 2021 08:00 CET Prominent Sweden-based investor Erik Selin commits anchor investment Stockholm, Sweden ...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Intrance Medical

How much funding has Intrance Medical raised?

Intrance Medical has raised $25M in total across 2 funding rounds.

What funding rounds has Intrance Medical raised?

Parsers VC lists 2 funding rounds of Intrance Medical, among them a Series A round of $8M on Sep 20, 2021.

What has the press written about Intrance Medical?

Parsers VC has collected 8 articles mentioning Intrance Medical, among them “Tridentify AB signs Letter of Intent with Intrance Medical Systems Inc regarding purchase and delivery of its SaaS based cold chain safeguarding service” (Apr 27, 2023) and “Intrance Medical Systems Raises $17M in Series A Funding” (Jan 4, 2022).

Is Intrance Medical still active?

Yes, Intrance Medical is active; its latest activity on Parsers VC dates from Mar 13, 2025.